Ronald V. Swanson
2021
In 2021, Ronald V. Swanson earned a total compensation of $2.5M as Chief Scientific Officer at Tyra Biosciences, a 419% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $102,951 |
|---|---|
| Option Awards | $1,991,713 |
| Salary | $432,316 |
| Other | $921 |
| Total | $2,527,901 |
Swanson received $2M in option awards, accounting for 79% of the total pay in 2021.
Swanson also received $103K in non-equity incentive plan, $432.3K in salary and $921 in other compensation.
Rankings
In 2021, Ronald V. Swanson's compensation ranked 5,106th out of 12,415 executives tracked by ExecPay. In other words, Swanson earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,106 out of 12,415 | 59th |
Division Manufacturing | 2,149 out of 5,501 | 61st |
Major group Chemicals And Allied Products | 924 out of 2,371 | 61st |
Industry group Drugs | 825 out of 2,092 | 61st |
Industry Pharmaceutical Preparations | 589 out of 1,542 | 62nd |
Source: SEC filing on April 28, 2022.
Swanson's colleagues
We found three more compensation records of executives who worked with Ronald V. Swanson at Tyra Biosciences in 2021.